Posts by: Marisa Wexler

Having a sibling with Lennox-Gastaut syndrome and other seizure-causing conditions can take a psychological toll that is not always recognized by parents, research shows. The findings were published in Epilepsy and ... Read more

January 12, 2021January 13, 2021

Array of Motor Symptoms Seen to Most Bother Patients, Changing Over Time

Parkinson's News Today

As Parkinson’s disease progresses, the symptoms that are most bothersome to patients change, a survey study reports. Specifically, hallmark motor symptoms like dyskinesia (involuntary movements) and those affecting walking, balance and speech were ... Read more

January 7, 2021January 7, 2021

Ascentage Pharma’s APG-2575 Earns Orphan Drug Designation

Acute Myeloid Leukemia News

APG-2575, an investigational Bcl-2 inhibitor being developed by Ascentage Pharma, has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid leukemia ... Read more

December 18, 2020December 18, 2020

Genetic Testing and Counseling Mostly Seen Favorably in Study

Parkinson's News Today

Most people who undergo genetic testing and counseling related to Parkinson’s disease are satisfied with their experience and feel no substantially adverse psychological effects, a study reported. However, its findings ... Read more

December 16, 2020December 16, 2020

Brain-cleaning System Found in Pigs May Further Parkinson’s Research

Parkinson's News Today

For the first time, researchers have confirmed the existence of a system that helps to clear waste from the brain in mammals other than rodents. The findings may hold implications ... Read more

December 15, 2020December 15, 2020

MJFF Announces 5 Parkinson’s Clinical Trials in Need of Recruits

Parkinson's News Today

Participants are now being recruited for several clinical trials testing investigational treatments for Parkinson’s disease, The Michael J. Fox Foundation (MJFF) announced. Clinical trials are well-designed experiments conducted on human ... Read more

December 9, 2020December 9, 2020

New Paper-based Sensor Could Help Monitor PKU, Study Finds

Phenylketonuria News

A novel sensor that combines plant enzymes and nanomaterials can be used to measure levels of the amino acid phenylalanine in human blood, a new study shows. The sensor may be ... Read more

December 7, 2020December 7, 2020

Upcoming Clinical Trial Will Test Immunosuppressant in Slowing Parkinson’s

COVID-19 News, Parkinson's News Today

An upcoming clinical trial, known as the AZA-PD study, will test whether limiting the activity of the immune system through the use of an immunosuppressant can slow the progression of ... Read more

December 3, 2020December 3, 2020

FDA Approves Nuplazid for Capsule Sprinkling

Parkinson's News Today

The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Nuplazid (pimavanserin) that will allow the medication to be taken more easily by Parkinson’s ... Read more

December 2, 2020December 2, 2020

Parathyroid Status Affects Kidney Phosphate Reabsorption, Study Indicates

XLH News Today

Abnormal activity of the parathyroid glands can change the extent to which phosphate is reabsorbed by the kidneys in people with X-linked hypophosphatemia (XLH), a new study indicates. The study, ... Read more

December 2, 2020December 2, 2020

Xeomin Approved in Canada to Treat Excessive Drooling, Common in Parkinson’s

Parkinson's News Today

Xeomin (incobotulinumtoxinA) has been approved by Health Canada to treat adults with chronic sialorrhea — excessive drooling — a condition often experienced by people with neurological conditions like Parkinson’s disease. ... Read more

December 1, 2020December 1, 2020

Diabetes Medication Glibenclamide May Be Useful for Treating Parkinson’s, Study Suggests

Parkinson's News Today

Aggregates of alpha-synuclein alter the electrical activity of dopamine-producing neurons, demonstrating a mechanistic link between two key features of Parkinson’s disease, a new study reports. The findings also suggest that ... Read more

November 25, 2020November 25, 2020

New Genetic Sequencing Panel Could Help Diagnose XLH, Related Conditions

XLH News Today

A new genetic sequencing panel could be used to help diagnose X-linked hypophosphatemia (XLH) and related conditions. The panel was described in the European Journal of Endocrinology, in the study “Validation ... Read more

November 25, 2020November 25, 2020

Pfizer Invests in Homology Medicines, Supporting Gene Therapies for PKU

Phenylketonuria News

Homology Medicines, which specializes in gene therapies for rare diseases and is developing two potential such therapies — HMI-102 and HMI-103 — for people with phenylketonuria (PKU), has received a $60 million equity investment from Pfizer. ... Read more

November 24, 2020November 24, 2020

Loneliness Linked to Worse Parkinson’s Symptoms, Study Finds

COVID-19 News, Parkinson's News Today

People with Parkinson’s disease who are lonely are more likely to have more severe symptoms and worse quality of life, a new study shows. The findings highlight the importance of ... Read more